Google
VYGR — VOYAGER THERAPEUTICS INC (Healthcare >> Biotechnology)
VYGR FAQ
What is VYGR's ROE?
VOYAGER THERAPEUTICS INC reports a Return on Equity (ROE) of -67.16%.
What is VYGR's dividend yield?
VOYAGER THERAPEUTICS INC offers a dividend yield of 0.00%.
What is VYGR's Deepscope Quality Score?
Deepscope rates VYGR's overall financial quality at 0 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy VYGR?
Deepscope's AI Timing Score for VYGR is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does VYGR belong to?
VOYAGER THERAPEUTICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 3.32
Price
-0.11
(-3.21%)
Day Change
|
|
|---|
VYGR, ファンダメンタルスコアはnot good ( ファンダメンタル = 0) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
41% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 3.32 |
| PBV / Sector |
1.21 / 4.79
GOOD
|
| Earning Per Share | -1.85 |
| PE / Sector |
N/A / 17.89
|
| PEG or PE/Growth / Sector |
N/A / 0.56
|
| Average 1M Daily Value |
2.15 M
GREAT
|
| Average 1W Daily Value |
1.73 M
GREAT
|
| Timing Factors |
|
14% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-11 09:54:50 |
| Symbol | VYGR |
| Name | VOYAGER THERAPEUTICS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 60.42 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 209.66 / 8,963.32 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 75 Hayden Avenue, Lexington, MA, United States, 02421
Phone: 857 259 5340
Website: https://www.voyagertherapeutics.com
Employees: 141
Sector: Healthcare >> Biotechnology
Description: Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
